• Itraconazole in Candida Biofilm Research

  2026-08-24

  Itraconazole combines triazole antifungal activity with CYP3A4, hedgehog, and angiogenesis-related research utility. This guide translates the PP2A–autophagy findings in Candida albicans biofilms into practical assay design, controls, and troubleshooting steps.

• PPM-18 for iNOS and NF-κB Research

  2026-08-23

  PPM-18 enables mechanism-focused studies of inflammatory nitric oxide signaling by suppressing NF-κB-dependent iNOS expression rather than directly blocking NOS catalysis. This guide connects macrophage, sepsis, and exploratory cardiovascular workflows with practical dosing, formulation, readout, and troubleshooting strategies.

• PPM-18: Reframing iNOS Control in Sepsis Research

  2026-08-22

  PPM-18 offers a mechanistically defined way to study NF-κB-dependent iNOS expression, connecting inflammatory signaling, nitric oxide biology, and translational sepsis research while highlighting important cardiovascular and assay-design considerations.

• Oligo (dT) 25 Beads for mRNA Workflows

  2026-08-21

  Oligo (dT) 25 Beads streamline polyA tail mRNA capture from animal, plant, and tissue-derived samples. This guide connects a magnetic purification workflow to immune-aging research, direct cDNA synthesis, RT-PCR validation, and sequencing-ready RNA quality control.

• Trichostatin A (TSA) and Translational Chromatin Design

  2026-08-20

  A thought-leadership guide to using Trichostatin A (TSA) as a reversible HDAC perturbation tool, linking histone acetylation with chromatin accessibility, cell-state transitions, cancer research, and translational study design.

• LSE mRNA Delivery for Stronger T Cell Immunity

  2026-08-20

  A 2026 Cell Reports Medicine study engineered lipid nanoparticle-stabilized emulsions to direct mRNA toward antigen-presenting cells rather than predominantly nonimmune cells. The approach increased localized antigen presentation, supported durable T cell responses in mice, and improved activity across vaccine-comparator and tumor-model experiments.

• Nicotinamide Adenine Dinucleotide in Stress Assays

  2026-08-19

  Use NAD+ to connect redox metabolism with autophagy, PARP-linked DNA damage responses, and enzyme activity in stressed cancer-cell models. This workflow emphasizes time-resolved sampling, fresh reagent handling, and orthogonal validation rather than treating a single NAD+ measurement as a mechanistic endpoint.

• TDRD9 siRNA Nanoparticles in PA Lung Injury

  2026-08-19

  A 2026 Nature Communications study identifies TDRD9 as a regulator of neutrophil cuproptosis during Pseudomonas aeruginosa lung infection and develops hyaluronic acid-coated peptide nanoparticles for siRNA delivery. Across patient-derived cells, mouse models, and human lung organoids, TDRD9 silencing reduced neutrophil accumulation, inflammation, edema, and bacterial injury through the PD-L1/CD80/p38 MAPK axis.

• Dual-Action Inhibitors Tune p38α Dephosphorylation

  2026-08-18

  The reference study shows that selected p38α kinase inhibitors can do more than block catalysis: they can reshape the activation loop so that WIP1 dephosphorylates p38α more efficiently. Structural and biochemical evidence supports a dual-action model in which inhibitor binding suppresses signaling while accelerating removal of the activating phospho-threonine, suggesting a route toward more durable and selective kinase control.

• Viral RIPK3 Degradation Controls Inflammation

  2026-08-18

  Liu and colleagues identified a viral inducer of RIPK3 degradation, or vIRD, that recruits host SCF ubiquitin-ligase machinery to eliminate a central necroptosis kinase. Their experiments show that this viral strategy can increase orthopoxvirus replication and reshape inflammation in a RIPK3- and MLKL-dependent manner, providing a mechanistic link between proteasomal protein turnover and viral pathogenesis.

• 3-Hydroxybutyrate (BHBA) in Stroke Assays

  2026-08-17

  Discover how 3-hydroxybutyrate (BHBA) can be used to dissect ketone-body control of ferroptosis after ischemic injury. This assay-centered guide translates recent stroke research into practical decisions for metabolic, mitochondrial, and epigenetic experiments.

• Bifendate (DDB): Reliable Cell Assays

  2026-08-17

  Learn how Bifendate (DDB), SKU BA1823, can be integrated into cell viability, proliferation, cytotoxicity, autophagy, and hepatic lipid workflows. This scenario-based guide connects formulation controls and exposure design with peer-reviewed evidence to improve interpretation without overstating biological conclusions.

• Protein A/G Magnetic Beads: Practical Workflow

  2026-08-16

  Protein A/G Magnetic Beads (SKU K1305) provide Fc-directed magnetic capture for antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation from complex samples. They are intended for research workflows and should not be treated as clinically validated, diagnostic, or universally compatible with every antibody species or subclass.

• Y-27632 in Colorectal Organoid Assay Design

  2026-08-15

  Learn how Y-27632, a selective ROCK inhibitor, can be used as a controlled recovery variable in patient-derived colorectal organoids. This guide connects ROCK biology with polarity, matrix, sampling, and assay-interpretation decisions that determine whether organoid data are reproducible and biologically meaningful.

• ROS-Responsive LNPs for Tumor-Selective mRNA Delivery

  2026-08-14

  Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids and identified BAmP-TK-12 as a lipid nanoparticle component that preferentially promotes mRNA expression in tumor cells. Delivery of DUF5 mRNA depleted mutant RAS and produced stronger preclinical antitumor activity than a small-molecule RAS inhibitor, while also highlighting important questions about selectivity, biodistribution, and translational safety.

8566 records 1/572 page Next 12345 下5页 Last page